What is anisocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Anisocytosis

Anisocytosis is the presence of red blood cells (RBCs) of unequal sizes in the peripheral blood, quantitatively measured by the red blood cell distribution width (RDW), which reflects variability in erythrocyte volumes 1, 2.

Definition and Measurement

Anisocytosis represents heterogeneity in RBC size and is measured through two methods:

  • RDW-CV: The coefficient of variation of RBC volumes, calculated as (standard deviation of RBC volumes / mean corpuscular volume) × 100
  • RDW-SD: The standard deviation of erythrocyte volumes expressed in femtoliters 1

The RDW is the "gold standard" for quantifying RBC size variability, providing extreme precision compared to visual inspection of blood smears 2. While hematologists can semiquantitatively assess anisocytosis on peripheral blood films, automated cell counter analysis via RDW offers superior accuracy and reproducibility 2.

Clinical Significance

Normal Values

In healthy individuals, the coefficient of variation of RBC size is typically less than 14.0% 3. Values above this threshold indicate pathological anisocytosis.

Diagnostic Applications

Iron Deficiency vs. Thalassemia: Anisocytosis serves as a critical discriminator between these microcytic anemias. In iron deficiency with MCV <70 fL, the CV is always >14.0%, whereas in beta-thalassemia minor with similar microcytosis, CV remains <14.0% in 88% of cases 3. This distinction is clinically valuable for rapid differentiation without invasive testing.

Early Iron Deficiency Detection: Anisocytosis and increased percentage of microcytic cells are the first hematological abnormalities in iron deficiency, appearing before hemoglobin drops and when transferrin saturation falls below 32% 4. This makes RDW more sensitive than conventional red cell indices for detecting early iron depletion 4.

Prognostic Implications

Anisocytosis extends beyond simple anemia diagnosis and carries prognostic significance across multiple conditions:

  • Cardiovascular disease: Associated with myocardial fibrosis in heart failure with preserved ejection fraction (HFpEF), where combined anisocytosis and fibrosis identifies patients at 16-fold increased 2-year mortality risk 5
  • Inflammation marker: Reflects an inflammatory milieu and immune dysregulation 1, 5
  • Pregnancy complications: Associated with preeclampsia, gestational diabetes, and recurrent miscarriage 1
  • Sepsis identification: Monocyte distribution width (analogous concept) helps identify children at high risk for severe sepsis 6

Common Pitfalls

When interpreting anisocytosis, avoid assuming all microcytic anemias with elevated RDW represent iron deficiency. While this is the most common cause, genetic disorders of iron metabolism or heme synthesis (sideroblastic anemias) can present similarly 7. In these cases, unrecognized tissue iron loading may cause severe morbidity and mortality, making accurate diagnosis critical to avoid harmful iron supplementation 7.

The presence of anisocytosis with low-normal ferritin (>20 mg/L) combined with abnormal transferrin saturation should prompt consideration of genetic disorders rather than simple nutritional deficiency 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.